Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Neural Regeneration Research|December 26, 2022
CMT1A current gene therapy approaches and promising biomarkersMarina Stavrou, Kleopas A KleopaCurrent Opinion in Neurology|June 14, 2024
Gene therapies for CMT neuropathies: from the bench to the clinicMarina Stavrou, Kleopas A KleopaCurrent Protocols|June 26, 2024
Lumbar Intrathecal Injection in Adult and Neonatal MiceMarina Stavrou, Elena Georgiou, Kleopas A KleopaNeuroscience Letters|November 29, 2020
Genetic mechanisms of peripheral nerve diseaseMarina Stavrou, Irene Sargiannidou, Theodoulakis Christofi, et al.Regenerative Medicine|April 12, 2025
Developing a gene therapy for Charcot-Marie-Tooth disease: progress and challengesMarina Stavrou, Alexia Kagiava, Irene Sargiannidou, et al.Journal of the Peripheral Nervous System : JPNS|March 25, 2023
Charcot-Marie-Tooth neuropathies: Current gene therapy advances and the route toward translationMarina Stavrou, Alexia Kagiava, Irene Sargiannidou, et al.International Journal of Molecular Sciences|July 2, 2021
Emerging Therapies for Charcot-Marie-Tooth Inherited NeuropathiesMarina Stavrou, Irene Sargiannidou, Elena Georgiou, et al.Gene Therapy|May 12, 2026
A dose-escalation and safety gene therapy study in a model of CMT4C neuropathyElena Georgiou, Alexia Kagiava, Andreas Hentschel, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 29, 2023
AAV9-mediated SH3TC2 gene replacement therapy targeted to Schwann cells for the treatment of CMT4CElena Georgiou, Alexia Kagiava, Irene Sargiannidou, et al.Gene Therapy|March 11, 2021
AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathyAlexia Kagiava, Christos Karaiskos, Jan Richter, et al.Pageof 2